Vasopressin in CSF and plasma in depressed suicide attempters: Preliminary results

European Neuropsychopharmacology

Volumn 12, Issue 5, 2002, Pages 489-494

  Brunner, Jürgen ^a   Keck, Martin E ^a   Landgraf, Rainer ^a   Uhr, Manfred ^a   Namendorf, Christian ^a   Bronisch, Thomas ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Cerebrospinal fluid; Depression; Hypothalamic pituitary adrenocortical system; Monoamine metabolites; Suicide attempt; Vasopressin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; BENZODIAZEPINE DERIVATIVE; CHLORAL HYDRATE; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; HOMOVANILLIC ACID; HYDROCORTISONE; MONOAMINE; SEROTONIN; VASOPRESSIN;

5 HYDROXYINDOLEACETIC ACID BRAIN LEVEL; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOTROPIN TEST; DEPRESSION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LUMBAR PUNCTURE; MALE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PSYCHIATRIC DIAGNOSIS; RATING SCALE; SEROTONIN BLOOD LEVEL; SEROTONIN BRAIN LEVEL; SUICIDE ATTEMPT;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; ARGININE VASOPRESSIN; CORTICOTROPIN-RELEASING HORMONE; DEXAMETHASONE; FEMALE; HEXAMETHONIUM; HOMOVANILLIC ACID; HUMANS; HYDROCORTISONE; HYDROXYINDOLEACETIC ACID; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSMOLAR CONCENTRATION; POTASSIUM; PSYCHIATRIC STATUS RATING SCALES; SODIUM; SUICIDE, ATTEMPTED;

EID: 0036788870     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(02)00071-8     Document Type: Article

References (38)

1. Altemus M., Swedo S.E., Leonard H.L., Richter D., Rubinow D.R., Potter W.Z., Rapoport J.L. Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine. Arch. Gen. Psychiatry. 51:1994;794-803.
2. Arató M., Bánki C.M., Bissette G., Nemeroff C.B. Elevated CSF CRF in suicide victims. Biol. Psychiatry. 25:1989;355-359.
3. Banki C.M., Bissette G., Arató M., O'Connor L., Nemeroff C.B. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am. J. Psychiatry. 144:1987;873-877.
4. Brunner J., Bronisch T. Neurobiological correlates of suicidal behaviour. Fortschr. Neurol. Psychiat. 67:1999;391-412.
5. Brunner J., Stalla G.K., Stalla J., Uhr M., Grabner A., Wetter T.C., Bronisch T. Decreased corticotropin-releasing hormone (CRH) concentrations in the cerebrospinal fluid of eucortisolemic suicide attempters. J. Psychiatr. Res. 35:2001;1-9.
6. Coccaro E.F., Kavoussi R.J., Hauger R.L., Cooper T.B., Ferris C.F. Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects. Arch. Gen. Psychiatry. 55:1998;708-714.
7. Coryell W., Schlesser M. The dexamethasone suppression test and suicide prediction. Am. J. Psychiatry. 158:2001;748-753.
8. Cremniter D., Jamain S., Kollenbach K., Alvarez J.C., Lecrubier Y., Gilton A., Jullien P., Lesieur P., Bonnet F., Spreux-Avroquaux O. CSF 5-HIAA levels are lower in impulsive as compared to nonimpulsive violent suicide attempters and control subjects. Biol. Psychiatry. 45:1999;1572-1579.
9. De Bellis M.D., Gold P.W., Geracioti T.D., Listwak S.J., Kling M.A. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine-vasopressin in patients with major depression. Am. J. Psychiatry. 150:1993;656-657.
10. De Goeij D.C.E., Jezova D., Tilders F.J.H. Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus. Brain Res. 577:1992;165-168.
11. Delville Y., Mansour K.M., Ferris C.F. Serotonin blocks vasopressin-facilitated offensive aggression: interactions within the ventrolateral hypothalamus of golden hamsters. Physiol. Behav. 59:1996;813-816.
12. Faull C.M., Charlton J.A., Butler T.J., Baylis P.H. The effect of acute pharmacological manipulation of central serotonin neurotransmission on osmoregulated secretion of arginine vasopressin in the rat. J. Endocrinol. 139:1993;77-87.
13. Ferris C.F. Serotonin diminishes aggression by suppressing the activity of the vasopressin system. Ann. NY Acad. Sci. 794:1996;98-103.
14. Ferris C.F., Delville Y. Vasopressin and serotonin interactions in the control of agonistic behavior. Psychoneuroendocrinology. 19:1994;593-601.
15. Ferris C.F., Melloni R.H., Koppel G., Perry K.W., Fuller R.W., Delville Y. Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters. J. Neurosci. 17:1997;4331-4340.
16. Gibbs D.M., Vale W. Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood. Brain. Res. 280:1983;176-179.
17. Heuser I., Bissette G., Dettling M., Schweiger U., Gotthardt U., Schmider J., Lammers C.H., Nemeroff C.B., Holsboer F. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment. Depress. Anxiety. 8:1998;71-79.
18. Heuser I., Yassouridis A., Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J. Psychiatr. Res. 28:1994;341-356.
19. Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J. Psychiatr. Res. 33:1999;181-214.
20. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 23:2000;477-501.
21. Inder W.J., Donald R.A., Prickett T.C.R., Frampton C.M., Sullivan P.F., Mulder R.T., Joyce P.R. Arginine vasopressin is associated with hypercortisolemia and suicide attempts in depression. Biol. Psychiatry. 42:1997;744-747.
22. Keck M.E., Holsboer F. Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders. Peptides. 22:2001;835-844.
23. Landgraf R., Kubota M., Holsboer F., Wotjak C.T. Release of vasopressin and oxytocin within the brain and into blood: microdialysis and antisense targeting. Saito T., Kurokawa K., Yoshida S., Neurohypophysis: Recent Progress of Vasopressin and Oxytocin Research. 1995;243-256 Elsevier, Amsterdam.
24. Landgraf R., Neumann I., Schwarzberg H. Central and peripheral release of vasopressin and oxytocin in the conscious rat after osmotic stimulation. Brain Res. 457:1988;219-225.
25. Landgraf R., Wotjak C.T., Neumann I.D., Engelmann M. Release of vasopressin within the brain contributes to neuroendocrine and behavioral regulation. Prog. Brain. Res. 119:1998;202-220.
26. Lester D. The dexamethasone suppression test as an indicator of suicide: a meta-analysis. Pharmacopsychiatry. 25:1992;265-270.
27. Lester D. The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis. Pharmacopsychiatry. 28:1995;45-50.
28. Mann J.J. The neurobiology of suicide. Nat. Med. 4:1998;25-30.
29. Mann J.J., Malone K.M. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients. Biol. Psychiatry. 4:1997;162-171.
30. Pitts A.F., Samuelson S.D., Meller W.H., Bissette G., Nemeroff C.B., Kathol R.G. Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls. Biol. Psychiatry. 38:1995;330-335.
31. Robinson I.C.A.F., Coombes J.E. Neurohypophysial peptides in cerebrospinal fluid: an update. Ann. NY Acad. Sci. 689:1993;269-284.
32. Roy A. Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression. Biol. Psychiatry. 32:1992;812-816.
33. Scott L.V., Dinan T.G. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. Life Sci. 62:1998;1985-1998.
34. Sørensen P.S. Studies of vasopressin in the human cerebrospinal fluid. Acta Neurol. Scand. 74:1986;81-102.
35. Träskman-Bendz L., Ekman R., Regnéll G., Öhman R. HPA-related CSF neuropeptides in suicide attempters. Eur. Neuropsychopharmacol. 2:1992;99-106.
36. Wible J.H., Zerbe R.L., Di Micco J.A. Benzodiazepine receptors modulate circulating plasma vasopressin concentration. Brain Res. 359:1985;368-370.
37. Wotjak C.T., Naruo T., Muraoka S., Simchen R., Landgraf R., Engelmann M. Forced swimming stimulates the expression of vasopressin and oxytocin in magnocellular neurons of the rat hypothalamic paraventricular nucleus. Eur. J. Neurosci. 13:2001;2273-2281.
38. Zobel A.W., Nickel T., Sonntag A., Uhr M., Holsboer F., Ising M. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression: a prospective study. J. Psychiatr. Res. 35:2001;83-94.